Seiji Fujiwara
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents.
Journal: International urology and nephrology
Published: January 19, 2022
Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor.
Journal: Urologic oncology
Published: October 14, 2021
Erratum: Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.
Journal: Molecular and clinical oncology
Published: June 28, 2021
Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: June 11, 2020
Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy.
Journal: Molecular and clinical oncology
Published: October 12, 2019
CUTANEOUS METASTASIS OF UROTHERIAL CARCINOMA FOR WHICH MOHS PASTE WAS USEFUL: A CASE REPORT
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 26, 2018
The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
Journal: Urologic oncology
Published: March 06, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026